Cleveland Clinic’s Director of Rare Cancers and Blood Diseases explains how having a formalized system in place for treating rare cancers can shorten the diagnostic odyssey and help improve patient outcomes and quality of life.Read More
CME program features advances and best practices in treating head and neck cancers.
Research team discovered synergies between two developmental pathways responsible for tumor progression in glioblastoma, in the hopes of identifying future therapeutic avenues.
Cleveland Clinic physician shares case of a patient with advanced triple-negative breast cancer achieving a durable response to 4th line therapy.
Numerous cancer treatments have been shown to have side effects such as ocular toxicities.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Two-day CME program highlights the latest diagnostic and treatment options for colorectal cancer.
The Community Outreach group at Cleveland Clinic’s Taussig Cancer Center sought input from people at local faith-based organizations to better understand and address the history of health disparities in the community.
In a recent podcast, a Taussig Cancer Center physician discusses treatment options, trials, and more for managing metastatic castrate-resistant prostate cancer.
New chair of Cleveland Clinic Taussig Cancer Center discusses his vision for improving equity of clinical trials and more
It’s essential for doctors to employ key building blocks of trust with patients.
Hematologist/oncologist Aaron Gerds, MD examines the subjectivity of clinical trial conclusions